51 – 60 of 172
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2019
-
Mark
Persistent elevation of fibrosis biomarker cartilage oligomeric matrix protein following hepatitis C virus eradication
(
- Contribution to journal › Article
-
Mark
Decreased biventricular longitudinal strain in patients with systemic sclerosis is mainly caused by pulmonary hypertension and not by systemic sclerosis per se
(
- Contribution to journal › Article
-
Mark
Higher plasma fibroblast growth factor 23 levels are associated with a higher risk profile in pulmonary arterial hypertension
(
- Contribution to journal › Article
-
Mark
CMR feature tracking in cardiac asymptomatic systemic sclerosis : Clinical implications
(
- Contribution to journal › Article
-
Mark
GWAS for systemic sclerosis identifies multiple risk loci and highlights fibrotic and vasculopathy pathways
(
- Contribution to journal › Article
- 2018
-
Mark
Common measure of quality of life for people with systemic sclerosis across seven European countries : A cross-sectional study
(
- Contribution to journal › Article
-
Mark
Gender differences in early systemic sclerosis patients : a report from the EULAR scleroderma trials and research group (EUSTAR) database
(
- Contribution to journal › Article
-
Mark
CCL21 as a Potential Serum Biomarker for Pulmonary Arterial Hypertension in Systemic Sclerosis
(
- Contribution to journal › Article
-
Mark
Increased right atrial volume measured with cardiac magnetic resonance is associated with worse clinical outcome in patients with pre-capillary pulmonary hypertension
(
- Contribution to journal › Article
-
Mark
Immunogenicity and safety of pneumococcal vaccination in patients with systemic sclerosis
(
- Contribution to journal › Article